Novo Nordisk beats expectations – upgrades outlook
Pharmaceutical company Novo Nordisk increased its net result in Q1 compared with the same period last year, thereby beating analyst expectations. Now, it's upgrading its outlook for 2021.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
In the first three months of the year, Danish pharmaceutical company Novo Nordisk's net result increased steadily, while its top line has landed at the same level as last year, according to the firm's interim report for Q1 which was published Monday morning.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analyst: Novo Nordisk's year may start with zero growth
For subscribers
.jpg)
.jpg&w=384&q=75)
